CNBX Pharmaceuticals Inc
OTC:CNBX
CNBX Pharmaceuticals Inc
OTC:CNBX
Price:
0.0001
USD
-50%
Market Closed
Market Cap:
$87.1k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
CNBX Pharmaceuticals Inc
OTC:CNBX
|
US |
Balance Sheet
Balance Sheet Decomposition
CNBX Pharmaceuticals Inc
CNBX Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
CNBX Pharmaceuticals Inc
CNBX Pharmaceuticals Inc
Balance Sheet
CNBX Pharmaceuticals Inc
CNBX Pharmaceuticals Inc
Currency: USD
| Aug-2005 | Aug-2006 | Aug-2007 | Aug-2008 | Aug-2009 | Aug-2010 | Aug-2011 | Aug-2012 | Aug-2013 | Aug-2014 | Aug-2015 | Aug-2016 | Aug-2017 | Aug-2018 | Aug-2019 | Aug-2020 | Aug-2021 | Aug-2022 | Aug-2023 | Aug-2024 | Aug-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
2
|
4
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+467%
|
0
+88%
|
0
-9%
|
0
-38%
|
0
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+57%
|
0
-73%
|
0
-33%
|
4
+18 100%
|
3
-13%
|
15
+377%
|
2
-85%
|
3
+39%
|
1
-74%
|
1
-38%
|
0
-94%
|
0
-41%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
2
|
3
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+67%
|
0
N/A
|
0
+260%
|
0
-61%
|
0
+386%
|
0
+44%
|
1
+43%
|
1
-23%
|
0
-19%
|
0
+2%
|
1
+182%
|
2
+92%
|
3
+3%
|
3
0%
|
3
+0%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
4
|
7
|
6
|
14
|
17
|
21
|
24
|
25
|
25
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
6
|
10
|
15
|
15
|
17
|
18
|
22
|
22
|
23
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
+113%
|
0
-9%
|
0
-41%
|
0
-65%
|
0
N/A
|
0
N/A
|
0
-120%
|
0
N/A
|
0
N/A
|
0
-52%
|
3
N/A
|
3
-10%
|
15
+456%
|
2
-88%
|
2
+3%
|
2
N/A
|
2
-24%
|
2
-23%
|
2
-1%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+467%
|
0
+88%
|
0
-9%
|
0
-38%
|
0
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+57%
|
0
-73%
|
0
-33%
|
4
+18 100%
|
3
-13%
|
15
+377%
|
2
-85%
|
3
+39%
|
1
-74%
|
1
-38%
|
0
-94%
|
0
-41%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
23
|
31
|
554
|
|
Switch to:
Switch to:
See Also
Discover More
